A two-year surveillance in five Colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 1, 2016, Pages 332-342

  Ocampo, Ana M ^a   Chen, Liang ^b   Cienfuegos, Astrid V ^a   Roncancio, Gustavo ^c   Chavda, Kalyan D ^b   Kreiswirth, Barry N ^b   Natalia Jimenez J ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b RUTGERS UNIVERSITY   (United States)

^c CardioVID Clinic   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE; BETA LACTAMASE CMY; BETA LACTAMASE CTX M; BETA LACTAMASE IMP; BETA LACTAMASE NDM; BETA LACTAMASE OXA 48; BETA LACTAMASE SMV; BETA LACTAMASE TEM; BETA LACTAMASE VIM; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; COLOMBIA; CROSS-SECTIONAL STUDY; ENTEROBACTERIACEAE; FEMALE; GENE LOCUS; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; CELL CLONE; CHEMISTRY; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIOLOGICAL MONITORING; GENE EXPRESSION; GENETICS; HORIZONTAL GENE TRANSFER; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PHYLOGENY; PLASMID; TERTIARY CARE CENTER; TRANSMISSION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CLONE CELLS; COLOMBIA; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGICAL MONITORING; FEMALE; GENE EXPRESSION; GENE TRANSFER, HORIZONTAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PLASMIDS; TERTIARY CARE CENTERS;

EID: 84957894745     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01775-15     Document Type: Article

References (70)

1. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. 2014. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 22:686-696. http://dx.doi.org/10.1016/j.tim.2014.09.003.
2. Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228-236. http://dx.doi.org/10.1016/S1473-3099(09)70054-4.
3. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. 2009. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30:666-671. http://dx.doi.org/10.1086/598244.
4. Chen LF, Anderson DJ, Paterson DL. 2012. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist 5:133-141. http://dx.doi.org/10.2147/IDR.S26613.
5. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785-796. http://dx.doi.org/10.1016/S1473-3099(13)70190-7.
6. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161. http://dx.doi.org/10.1128/AAC.45.4.1151-1161.2001.
7. KPC) variants. J Clin Microbiol 49:579-585. http://dx.doi.org/10.1128/JCM.01588-10.
8. Arnold RS, Thom KA, Sharma S, Phillips M, Johnson JK, Morgan DJ. 2011. Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J 104:40-45. http://dx.doi.org/10.1097/SMJ.0b013e3181fd7d5a.
9. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:1028-1033. http://dx.doi.org/10.1128/AAC.01020-07.
10. Chen L, Mathema B, Pitout JD, DeLeo FR, Kreiswirth BN. 2014. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio 5:e01355-14. http://dx.doi.org/10.1128/mBio.01355-14.
11. Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, Chavda KD, Jacobs MR, Mathema B, Olsen RJ, Bonomo RA, Musser JM, Kreiswirth BN. 2014. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A111:4988-4993. http://dx.doi.org/10.1073/pnas.1321364111.
12. Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP, Colombian Nosocomial Resistance Study Group. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 50:2880-2882. http://dx.doi.org/10.1128/AAC.00186-06.
13. Lopez JA, Correa A, Navon-Venezia S, Correa AL, Torres JA, Briceno DF, Montealegre MC, Quinn JP, Carmeli Y, Villegas MV. 2011. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect 17:52-56. http://dx.doi.org/10.1111/j.1469-0691.2010.03209.x.
14. Mojica MF, Correa A, Vargas DA, Maya JJ, Montealegre MC, Rojas LJ, Ruiz SJ, Quinn JP, Villegas MV, Colombian Nosocomial Bacterial Resistance Study Group. 2012. Molecular correlates of the spread of KPC-producing Enterobacteriaceae in Colombia. Int J Antimicrob Agents 40:277-279. http://dx.doi.org/10.1016/j.ijantimicag.2012.05.006.
15. Leal AL, Buitrago G, Cortes JA, Ovalle MV, Alvarez CA, Castillo JS, La Rotta J, Galo S, Colombian Group For Tigecycline Susceptibility Surveillance. 2009. In vitro activity of tigecycline and other broad spectrum antibiotics against microorganisms isolated from infected patients in Colombia. Clin Microbiol Infect 15(S4):S625.
16. Pacheco R, Osorio L, Correa AM, Villegas MV. 2014. Prevalence of Gram-negative bacteria harboring bla KPC gene in Colombian hospitals. Biomedica 34(Suppl 1):S81-S90. (In Spanish.) http://dx.doi.org/10.1590/S0120-41572014000500010.
17. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, Colombian Nosocomial Resistance Study Group. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 51: 1553-1555. http://dx.doi.org/10.1128/AAC.01405-06.
18. Saavedra SY, Duarte C, Gonzalez MN, Realpe ME. 2014. Characterization of isolates of carbapenemase-producing Pseudomonas aeruginosa from seven Colombian provinces. Biomedica 34(Suppl 1):S217-S223. (In Spanish.) http://dx.doi.org/10.1590/S0120-41572014000500024.
19. Vanegas JM, Cienfuegos AV, Ocampo AM, Lopez L, del Corral H, Roncancio G, Sierra P, Echeverri-Toro L, Ospina S, Maldonado N, Robledo C, Restrepo A, Jimenez JN. 2014. Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellin, Colombia. J Clin Microbiol 52:3978-3986. http://dx.doi.org/10.1128/JCM.01879-14.
20. Gales AC, Castanheira M, Jones RN, Sader HS. 2012. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 73:354-360. http://dx.doi.org/10.1016/j.diagmicrobio.2012.04.007.
21. Ovalle M, Beltrán M. 2014. Vigilancia de resistencia bacteriana a través de las bases de datos Whonet, on Sistema Nacional de Vigilancia de IAAS y Resistencia Bacteriana. Instituto Nacional de Salud de Colombia, Bogotá, Colombia. http://www.ins.gov.co/tramites-y-servicios/examenes-deinter%C3%A9s-en-salud-publica/Microbiologa/Informe%20de%20resistencia%20Bacteriana%20a%C3%B1o%20%202013.pdf. Accessed 30 September 2015.
22. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P, Peixe L, Pournaras S, Rossolini GM, Tsakris A, Vatopoulos A, Canton R. 2010. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 16: 112-122. http://dx.doi.org/10.1111/j.1469-0691.2009.03116.x.
23. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, Rossolini GM, Souli M, Giamarellou H. 2010. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 16:102-111. http://dx.doi.org/10.1111/j.1469-0691.2009.03115.x.
24. Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309-332. http://dx.doi.org/10.1016/j.ajic.2008.03.002.
25. CLSI. 2015. Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement. CLSI document M100-S25. CLSI, Wayne, PA.
26. Ellington MJ, Kistler J, Livermore DM, Woodford N. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 59:321-322.
27. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119-123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
28. Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65:490-495. http://dx.doi.org/10.1093/jac/dkp498.
29. Chen L, Chavda KD, Mediavilla JR, Zhao Y, Fraimow HS, Jenkins SG, Levi MH, Hong T, Rojtman AD, Ginocchio CC, Bonomo RA, Kreiswirth BN. 2012. Multiplex real-time PCR for detection of an epidemic KPC-producing Klebsiella pneumoniae ST258 clone. Antimicrob Agents Chemother 56:3444-3447. http://dx.doi.org/10.1128/AAC.00316-12.
30. Breurec S, Guessennd N, Timinouni M, Le TA, Cao V, Ngandjio A, Randrianirina F, Thiberge JM, Kinana A, Dufougeray A, Perrier-Gros-Claude JD, Boisier P, Garin B, Brisse S. 2013. Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with two major international clonal groups, CG15 and CG258. Clin Microbiol Infect 19: 349-355. http://dx.doi.org/10.1111/j.1469-0691.2012.03805.x.
31. Chen L, Chavda KD, Findlay J, Peirano G, Hopkins K, Pitout JD, Bonomo RA, Woodford N, DeLeo FR, Kreiswirth BN. 2014. Multiplex PCR for identification of two capsular types in epidemic KPC-producing Klebsiella pneumoniae sequence type 258 strains. Antimicrob Agents Chemother 58:4196-4199. http://dx.doi.org/10.1128/AAC.02673-14.
32. Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, Ersoy Y, Aktas E, Gursoy NC, Caliskan A. 2009. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis 62:372-377.
33. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178-4182. http://dx.doi.org/10.1128/JCM.43.8.4178-4182.2005.
34. Mathers AJ, Stoesser N, Sheppard AE, Pankhurst L, Giess A, Yeh AJ, Didelot X, Turner SD, Sebra R, Kasarskis A, Peto T, Crook D, Sifri CD. 2015. Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from wholegenome sequencing. Antimicrob Agents Chemother 59:1656-1663. http://dx.doi.org/10.1128/AAC.04292-14.
35. Bogdanovich T, Adams-Haduch JM, Tian GB, Nguyen MH, Kwak EJ, Muto CA, Doi Y. 2011. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis 53:373-376. http://dx.doi.org/10.1093/cid/cir401.
36. Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, Tarasi A, Parisi G, Lappa A, Carattoli A, Petrosillo N, SEERBIO-GRAB Network. 2013. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 19:E23-E30. http://dx.doi.org/10.1111/1469-0691.12070.
37. Mammina C, Bonura C, Di Bernardo F, Aleo A, Fasciana T, Sodano C, Saporito MA, Verde MS, Tetamo R, Palma DM. 2012. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill 17(33): pii=20248. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20248.
38. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM. 2014. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 19(42):14-18. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20939.
39. Pereira PS, de Araujo CF, Seki LM, Zahner V, Carvalho-Assef AP, Asensi MD. 2013. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother 68:312-316. http://dx.doi.org/10.1093/jac/dks396.
40. Tóth A, Damjanova I, Puskas E, Janvari L, Farkas M, Dobak A, Borocz K, Paszti J. 2010. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis 29:765-769. http://dx.doi.org/10.1007/s10096-010-0921-3.
41. Valentín-Martín A, Valverde-De Francisco A, Bosque-Vall M, Canton-Moreno R. 2013. First report of colistin-resistant KPC-2 producing ST258-Klebsiella pneumoniae in Spain. Enferm Infecc Microbiol Clin 31: 489-491. http://dx.doi.org/10.1016/j.eimc.2012.12.002.
42. van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Richter SS, Cline M, Hall GS, Kaye KS, Jacobs MR, Kalayjian RC, Salata RA, Segre JA, Conlan S, Evans S, Fowler VG, Jr, Bonomo RA. 2014. Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother 58:4035-4041. http://dx.doi.org/10.1128/AAC.02636-14.
43. Lee GC, Burgess DS. 2012. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob 11:32. http://dx.doi.org/10.1186/1476-0711-11-32.
44. Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. 2011. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 37:415-419. http://dx.doi.org/10.1016/j.ijantimicag.2011.01.012.
45. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35:736-755. http://dx.doi.org/10.1111/j.1574-6976.2011.00268.x.
46. Arena F, Giani T, Becucci E, Conte V, Zanelli G, D'Andrea MM, Buonocore G, Bagnoli F, Zanchi A, Montagnani F, Rossolini GM. 2013. Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC beta-lactamase in a neonatal intensive care unit. J Clin Microbiol 51:4067-4072. http://dx.doi.org/10.1128/JCM.01982-13.
47. NDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 56:2735-2738. http://dx.doi.org/10.1128/AAC.06142-11.
48. Poirel L, Yilmaz M, Istanbullu A, Arslan F, Mert A, Bernabeu S, Nordmann P. 2014. Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother 58:2929-2933. http://dx.doi.org/10.1128/AAC.02047-13.
49. Cubero M, Calatayud L, Ayats J, Pena C, Martin R, Linares J, Dominguez MA, Ardanuy C. 2013. Clonal spread of Klebsiella pneumoniae producing OXA-1 betalactamase in a Spanish hospital. Int Microbiol 16: 227-233.
50. CTX-M-15 in a neonatal unit of a tertiary care hospital in Tanzania. Int J Antimicrob Agents 38:265-269. http://dx.doi.org/10.1016/j.ijantimicag.2011.05.009.
51. Poirel L, Revathi G, Bernabeu S, Nordmann P. 2011. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 55:934-936. http://dx.doi.org/10.1128/AAC.01247-10.
52. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046-5054. http://dx.doi.org/10.1128/AAC.00774-09.
53. Poirel L, Al Maskari Z, Al Rashdi F, Bernabeu S, Nordmann P. 2011. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 66:304-306. http://dx.doi.org/10.1093/jac/dkq428.
54. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG. 2009. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53:3365-3370. http://dx.doi.org/10.1128/AAC.00126-09.
55. Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, Gales AC, Venezia SN, Quinn JP, Nordmann P. 2010. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 16:1349-1356. http://dx.doi.org/10.3201/eid1609.091389.
56. Castanheira M, Farrell SE, Wanger A, Rolston KV, Jones RN, Mendes RE. 2013. Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages. Microb Drug Resist 19:295-297. http://dx.doi.org/10.1089/mdr.2012.0238.
57. Perez F, Van Duin D. 2013. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med 80:225-233. http://dx.doi.org/10.3949/ccjm.80a.12182.
58. Geraci DM, Bonura C, Giuffre M, Saporito L, Graziano G, Aleo A, Fasciana T, Di Bernardo F, Stampone T, Palma DM, Mammina C. 2015. Is the monoclonal spread of the ST258, KPC-3-producing clone being replaced in southern Italy by the dissemination of multiple clones of carbapenem-nonsusceptible, KPC-3-producing Klebsiella pneumoniae? Clin Microbiol Infect 21:e15-e17. http://dx.doi.org/10.1016/j.cmi.2014.08.022.
59. Gona F, Barbera F, Pasquariello AC, Grossi P, Gridelli B, Mezzatesta ML, Caio C, Stefani S, Conaldi PG. 2014. In vivo multiclonal transfer of bla(KPC-3) from Klebsiella pneumoniae to Escherichia coli in surgery patients. Clin Microbiol Infect 20:O633-O635. http://dx.doi.org/10.1111/1469-0691.12577.
60. Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P. 2014. High rate of faecal carriage of extended-spectrum beta-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect 20:350-354. http://dx.doi.org/10.1111/1469-0691.12325.
61. Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, Samonis G. 2014. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study. J Infect Chemother 20:293-297. http://dx.doi.org/10.1016/j.jiac.2013.11.007.
62. Lee GC, Lawson KA, Burgess DS. 2013. Clinical epidemiology of carbapenem-resistant Enterobacteriaceae in community hospitals: a case-case-control study. Ann Pharmacother 47:1115-1121. http://dx.doi.org/10.1177/1060028013503120.
63. Brennan BM, Coyle JR, Marchaim D, Pogue JM, Boehme M, Finks J, Malani AN, VerLee KE, Buckley BO, Mollon N, Sundin DR, Washer LL, Kaye KS. 2014. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol 35:342-349. http://dx.doi.org/10.1086/675611.
64. Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y, Huang Y, Liu R. 2015. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Pathog Glob Health 109:68-74. http://dx.doi.org/10.1179/2047773215Y.0000000004.
65. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:1099-1106. http://dx.doi.org/10.1086/592412.
66. Wu D, Cai J, Liu J. 2011. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J 104:106-110. http://dx.doi.org/10.1097/SMJ.0b013e318206063d.
67. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. 2007. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 60:1124-1130. http://dx.doi.org/10.1093/jac/dkm356.
68. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, Maor Y, Rahav G. 2012. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 18:54-60. http://dx.doi.org/10.1111/j.1469-0691.2011.03478.x.
69. Gomez Rueda V, Zuleta Tobon JJ. 2014. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colomb Med (Cali) 45:54-60.
70. Qureshi ZA, Syed A, Clarke LG, Doi Y, Shields RK. 2014. Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria. Antimicrob Agents Chemother 58:3100-3104. http://dx.doi.org/10.1128/AAC.02445-13.